Burning Rock Biotech (Burning Rock Biotech) EV-to-Revenue : 0.05 (As of Apr. 26, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Burning Rock Biotech's enterprise value is $4.24 Mil. Burning Rock Biotech's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $78.99 Mil. Therefore, Burning Rock Biotech's EV-to-Revenue for today is 0.05.

The historical rank and industry rank for Burning Rock Biotech's EV-to-Revenue or its related term are showing as below:

BNR' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.19 Med: 2.81 Max: 58.01
Current: 0.05

During the past 6 years, the highest EV-to-Revenue of Burning Rock Biotech was 58.01. The lowest was -0.19. And the median was 2.81.

BNR's EV-to-Revenue is ranked better than
95.13% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.07 vs BNR: 0.05

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-26), Burning Rock Biotech's stock price is $0.85. Burning Rock Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.77. Therefore, Burning Rock Biotech's PS Ratio for today is 1.10.

Burning Rock Biotech EV-to-Revenue Historical Data

The historical data trend for Burning Rock Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech EV-to-Revenue Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

31.59

9.79

1.34

Burning Rock Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial															1.35	1.34	2.17	1.47	0.19

Competitive Comparison of Burning Rock Biotech's EV-to-Revenue

For the Diagnostics & Research subindustry, Burning Rock Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's EV-to-Revenue falls into.

Burning Rock Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Burning Rock Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4.240	/	78.988
	=	0.05

Burning Rock Biotech's current Enterprise Value is $4.24 Mil.
Burning Rock Biotech's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $78.99 Mil.

Burning Rock Biotech (NAS:BNR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Burning Rock Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.85	/	0.771
	=	1.10

Burning Rock Biotech's share price for today is $0.85.
Burning Rock Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.77.

Burning Rock Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.